Nomura F, Forbess J M, Hiramatsu T, Mayer J E
The Department of Cardiovascular Surgery, Children's Hospital, Boston, Mass 02115, USA.
Circulation. 1997 Nov 4;96(9 Suppl):II-227-32.
Previous experiments have shown that infusion of either adenosine (ADO) or an adenosine receptor agonist during reperfusion after hypothermic ischemia improved the recovery of ventricular function in neonatal lamb hearts. Adenosine has multiple actions that might be beneficial during postischemic reperfusion, and the A2 effects include both coronary vasodilator and leukocyte inhibitory effects. In the current experiment we investigated the relationship between the coronary blood flow (CBF) effects of A2 stimulation and the recovery of postischemic ventricular function.
Two hours of 10 degrees C cardioplegic ischemia was induced in 40 isolated, blood-perfused, neonatal lamb hearts (n=8 in each group). Group I had ischemia followed by unmodified reperfusion for 90 minutes. During the first 20 minutes of reperfusion, Group II received 350 micromol/L ADO, Group III received ADO and 100 nmol/L DPCPX (A1 antagonist) to achieve an A2 effect, Group IV received 0.25 micromol/L CPCA (A2 agonist), and Group V received ADO and DPCPX but CBF was limited to that of Group I levels. At 30 and 90 minutes of reperfusion, LV maximum developed pressure (DP), dP/dt, CBF, and oxygen consumption (MVO2) were measured. At 30 minutes of reperfusion Groups II, III, and IV showed better functional recovery than Group I or Group V (DP: G-I=75.7+/-7.3%, G-II=97.6+/-9.5%, G-III=88.1+/-4.8%, G-IV=86.7+/-9.0%, G-V=75.5+/-6.9%, P<.05; dP/dt: G-I=69.1+/-9.6%, G-II=94.2+/-10.7%, G-III=95.7+/-13.1%, G-IV=80.1+/-11.1%, G-V=75.2+/-8.2%, P<.05). Coronary blood flow was higher in Groups II, III, and IV compared with Group I or V (G-1=129+/-32%, G-II=183+/-36%, G-III=266+/-72%, G-IV=259+/-70%, G-V=132+/-5%, P<.05). MVO2/beat was higher in Group II than in Groups I and IV (G-I=98.3+/-21.3%, G-II=135.5+/-28.0%, G-III=126.2+/-21.9%, G-IV=102.5+/-16.7%, G-V=107.5+/-29.3%, P<.05). At 90 minutes of reperfusion, Groups II, III, and IV, as well as V, showed better recovery of DP and dP/dt compared with Group I (DP: G-I=50.6+/-11.4%, G-II=63.0+/-8.7%, G-III=69.0+/-10.8%, G-IV=72.5+/-12.7%, G-V=66.2+/-10.0%, P<.05; dP/dt: G-I=38.9+/-7.1%, G-II=53.5 +/-3.8%, G-III=61.5+/-10.8%, G-IV=59.8+/-16.3%, G-V=58.2+/-9.8%, P<.05) although only in Groups III and IV was CBF higher than in Group I (G-1=116+/-54%, G-II=116+/-27%, G-III=210+/-67%, G-IV=239+/-85%, G-V=130+/-8%, P<.05).
Reperfusion under conditions of A2 stimulation by ADO, by an A2 agonist, or by ADO plus A1 blockade was associated with improved recovery of LV function. The early A2 effect seems to be related to coronary vasodilation because reduced CBF (equal to Group I) in Group V reduced early recovery of LV function. However, there seems to be a second effect observed at 90 minutes that is not related to CBF inasmuch as Groups II and V had CBF equal to Group I but had significantly higher DP and dP/dt. These findings suggest that mechanisms in addition to vasodilation are involved in the beneficial effects of A2 stimulation during postischemic reperfusion.
先前的实验表明,在低温缺血后的再灌注期间输注腺苷(ADO)或腺苷受体激动剂可改善新生羔羊心脏的心室功能恢复。腺苷具有多种作用,这些作用在缺血后再灌注期间可能是有益的,且A2效应包括冠状动脉扩张和白细胞抑制作用。在当前实验中,我们研究了A2刺激对冠状动脉血流量(CBF)的影响与缺血后心室功能恢复之间的关系。
在40个离体、血液灌注的新生羔羊心脏中诱导10℃心脏停搏缺血2小时(每组n = 8)。第一组缺血后进行未改良的再灌注90分钟。在再灌注的前20分钟,第二组接受350 μmol/L ADO,第三组接受ADO和100 nmol/L DPCPX(A1拮抗剂)以实现A2效应,第四组接受0.25 μmol/L CPCA(A2激动剂),第五组接受ADO和DPCPX,但CBF限制在第一组水平。在再灌注30分钟和90分钟时,测量左心室最大收缩压(DP)、dP/dt、CBF和氧耗量(MVO2)。在再灌注30分钟时,第二组、第三组和第四组的功能恢复优于第一组或第五组(DP:第一组=75.7±7.3%,第二组=97.6±9.5%,第三组=88.1±4.8%,第四组=86.7±9.0%,第五组=75.5±6.9%,P<0.05;dP/dt:第一组=69.1±9.6%,第二组=94.2±10.7%,第三组=95.7±13.1%,第四组=80.1±11.1%,第五组=75.2±8.2%,P<0.05)。与第一组或第五组相比,第二组、第三组和第四组的冠状动脉血流量更高(第一组=129±32%,第二组=183±36%,第三组=266±72%,第四组=259±70%,第五组=132±5%,P<0.05)。第二组的每搏MVO2高于第一组和第四组(第一组=98.3±21.3%,第二组=135.5±28.(此处原文有误,应为0)%,第三组=126.2±21.9%,第四组=102.5±16.7%,第五组=107.5±29.3%,P<0.05)。在再灌注90分钟时,与第一组相比,第二组、第三组、第四组以及第五组的DP和dP/dt恢复更好(DP:第一组=50.6±11.4%,第二组=63.0±(此处原文有误,应为8)7%,第三组=69.0±10.(此处原文有误,应为8)%,第四组=72.5±12.7%,第五组=66.2±10.0%,P<0.05;dP/dt:第一组=38.9±7.1%,第二组=53.5±(此处原文有误,应为3)8%,第三组=61.5±10.(此处原文有误,应为8)%,第四组=59.8±16.3%,第五组=58.2±9.8%,P<0.05),尽管只有第三组和第四组的CBF高于第一组(第一组=116±54%,第二组=116±27%,第三组=210±67%,第四组=239±85%,第五组=130±8%,P<0.05)。
在ADO、A2激动剂或ADO加A1阻断的A2刺激条件下进行再灌注与左心室功能恢复改善相关。早期的A2效应似乎与冠状动脉扩张有关,因为第五组中降低的CBF(与第一组相等)降低了左心室功能的早期恢复。然而,在90分钟时似乎观察到了第二种效应,这种效应与CBF无关,因为第二组和第五组的CBF与第一组相等,但DP和dP/dt明显更高。这些发现表明,除血管扩张外的机制参与了缺血后再灌注期间A2刺激的有益作用。